Remeron Related Published Studies
Well-designed clinical trials related to Remeron (Mirtazapine)
Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation. [2009.07]
Influence of sex and CYP2D6 genotype on mirtazapine disposition, evaluated in Spanish healthy volunteers. [2009.06]
Early effects of mirtazapine on emotional processing. [2009.05]
Mirtazapine add-on therapy in the treatment of schizophrenia with atypical antipsychotics: a double-blind, randomised, placebo-controlled clinical trial. [2009.04]
Mirtazapine, a sedating antidepressant, and improved driving safety in patients with major depressive disorder: a prospective, randomized trial of 28 patients. [2009.03]
Add-on mirtazapine enhances antipsychotic effect of first generation antipsychotics in schizophrenia: a double-blind, randomized, placebo-controlled trial. [2009.03]
Add-on mirtazapine enhances antipsychotic effect of first generation antipsychotics in schizophrenia: A double-blind, randomized, placebo-controlled trial. [2009.01.12]
The impact of reboxetine and mirtazapine on driving simulator performance and psychomotor function in depressed patients. [2008.12]
Neuroimaging of mirtazapine enantiomers in humans. [2008.10]
Mirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression: systematic review and meta-analysis. [2008.09]
Two randomized placebo-controlled trials to evaluate the efficacy and tolerability of mirtazapine for the treatment of obstructive sleep apnea. [2008.06.01]
A placebo-controlled trial of mirtazapine for the management of methamphetamine withdrawal. [2008.05]
Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression. [2008.04]
Mirtazapine decreases the pain feeling in healthy participants. [2008.02]
Venlafaxine versus Mirtazapine in the Treatment of Undifferentiated Somatoform Disorder : A 12-Week Prospective, Open-Label, Randomized, Parallel-Group Trial. [2008]
Treatment of post-myocardial infarction depressive disorder: a randomized, placebo-controlled trial with mirtazapine. [2007.09]
The MAOA T941G polymorphism and short-term treatment response to mirtazapine and paroxetine in major depression. [2007.04.05]
Combination of low-dose mirtazapine and ibuprofen for prophylaxis of chronic tension-type headache. [2007.02]
Efficacy of mirtazapine in obstructive sleep apnea syndrome. [2007.01.01]
Effect of mirtazapine orally disintegrating tablets on health-related quality of life in elderly depressed patients with comorbid medical disorders: a pilot study. [2007.01]
Effect of mirtazapine orally disintegrating tablets on health-related quality of life in elderly depressed patients with comorbid medical disorders: a pilot study. [2007]
The MAOA T941G polymorphism and short-term treatment response to mirtazapine and paroxetine in major depression. [2006.12.27]
Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report. [2006.09]
A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report. [2006.07]
Time course of hypothalamic-pituitary-adrenocortical axis activity during treatment with reboxetine and mirtazapine in depressed patients. [2006.07]
Low-dose mirtazapine: a new option in the treatment of antipsychotic-induced akathisia. A randomized, double-blind, placebo- and propranolol-controlled trial. [2006.06.01]
Cerebrovascular reactivity following administration of mirtazapine in healthy probands--a randomized, placebo controlled double-blind clinical study. [2006.06]
Mirtazapine Orally Disintegrating Tablets Versus Venlafaxine Extended Release: A Double-blind, Randomized Multicenter Trial Comparing the Onset of Antidepressant Response in Patients With Major Depressive Disorder. [2006.02]
Mirtazapine treatment of social phobia in women: a randomized, double-blind, placebo-controlled study. [2005.12]
Mirtazapine in amphetamine detoxification: a placebo-controlled pilot study. [2005.09]
Mirtazapine for obsessive-compulsive disorder: an open trial followed by double-blind discontinuation. [2005.04]
Actual driving performance and psychomotor function in healthy subjects after acute and subchronic treatment with escitalopram, mirtazapine, and placebo: a crossover trial. [2005.04]
Comparison of mirtazapine and fluoxetine in the treatment of major depressive disorder: a double-blind, randomized trial. [2005.04]
Mirtazapine and venlafaxine in the management of collateral psychopathology during alcohol detoxification. [2005.01]
Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients. [2005]
Well-designed clinical trials possibly related to Remeron (Mirtazapine)
Is the antidepressant venlafaxine effective for the treatment of functional dyspepsia? [2009.02]
Impact of the WHO depression guideline on patient care by psychiatrists: a randomized controlled trial. [2008.09]
The effect of short-term, low-dose tricyclic and tetracyclic antidepressant treatment on satiation, postnutrient load gastrointestinal symptoms and gastric emptying: a double-blind, randomized, placebo-controlled trial. [2008.03]
Association analysis between variants of the interleukin-1beta and the interleukin-1 receptor antagonist gene and antidepressant treatment response in major depression. [2008.02]
Paroxetine versus placebo and other agents for depressive disorders: a systematic review and meta-analysis. [2007.12]
The effect of short-term, low-dose tricyclic and tetracyclic antidepressant treatment on satiation, postnutrient load gastrointestinal symptoms and gastric emptying: a double-blind, randomized, placebo-controlled trial. [2007.11.20]
A monoamine oxidase B gene variant and short-term antidepressant treatment response. [2007.10.01]
Nonresponse to treatment for depression following myocardial infarction: association with subsequent cardiac events. [2007.09]
The role of sedation tests in identifying sedative drug effects in healthy volunteers and their power to dissociate sedative-related impairments from memory dysfunctions. [2007.08]
A monoamine oxidase B gene variant and short-term antidepressant treatment response. [2007.06.07]
Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. [2007.04.18]
Verbal memory performance during subchronic challenge with a selective serotonergic and a mixed action antidepressant. [2006.10]
Serotonin transporter polymorphisms and side effects in antidepressant therapy--a pilot study. [2006.03]
Serotonergic modulation of neuronal responses to behavioural inhibition and reinforcing stimuli: an fMRI study in healthy volunteers. [2006.01]
Centrally active nonhormonal hot flash therapies. [2005.12.19]
Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder. [2005.09.20]
Imipramine dose in relation to therapeutic plasma level: are clinical trials using imipramine as a positive control flawed? [2005.09]
Venlafaxine extended release versus conventional antidepressants in the remission of depressive disorders after previous antidepressant failure: ARGOS study. [2005]
Other research related to Remeron (Mirtazapine)
Mirtazapine versus venlafaxine for the treatment of somatic symptoms associated with major depressive disorder: a randomized, open-labeled trial. [2009.09.30]
New onset somnambulism associated with different dosage of mirtazapine: a case report. [2009.07]
An open-label study of mirtazapine as treatment for combat-related PTSD. [2009.07]
Interaction of glia activation and neurotransmission in hippocampus of neuropathic rats treated with mirtazapine. [2009.06]
[Mirtazapine--pharmacologic action and clinical advantages] [2009.03]
Racemic intrathecal mirtazapine but not its enantiomers acts anti-neuropathic after chronic constriction injury in rats. [2009.01.20]
Mirtazapine, a sedating antidepressant, and improved driving safety in patients with major depressive disorder: A prospective, randomized trial of 28 patients. [2009.01.13]
Mirtazapine: a review of its use in major depression and other psychiatric disorders. [2009]
Prophylactic mirtazapine reduces intrathecal morphine-induced pruritus. [2008.11]
A meta-analysis of clinical trials comparing mirtazapine with selective serotonin reuptake inhibitors for the treatment of major depressive disorder. [2008.11]
Influence of mirtazapine on the hypotensive activity of enalapril and propranolol in spontaneously hypertensive rats. [2008.11]
The impact of reboxetine and mirtazapine on driving simulator performance and psychomotor function in depressed patients. [2008.10.07]
Symptoms and sleep patterns during inpatient treatment of methamphetamine withdrawal: a comparison of mirtazapine and modafinil with treatment as usual. [2008.10]
Role of mirtazapine in the treatment of antipsychotic-induced akathisia. [2008.06]
Effectiveness and tolerability of mirtazapine and amitriptyline in alcoholic patients with co-morbid depressive disorder: a randomized, double-blind study. [2008.06]
Neonatal recurrent prolonged hypothermia associated with maternal mirtazapine treatment during pregnancy. [2008.06]
Mirtazapine associated with profound hyponatremia: two case reports. [2008.06]
Employing mirtazapine to aid benzodiazepine withdrawal. [2008.06]
Mirtazapine augmentation in depressed patients with sexual dysfunction due to selective serotonin reuptake inhibitors. [2008.06]
Mirtazapine associated with recurrent pancreatitis - a case report. [2008.05]
Mirtazapine treatment in a subject with autistic disorder and fetishism. [2008.04]
Mirtazapine in the treatment of adolescent anorexia nervosa. Case-control study. [2008.04]
Effectiveness and tolerability of mirtazapine and amitriptyline in alcoholic patients with co-morbid depressive disorder: a randomized, double-blind study. [2008.03.10]
Symptoms and sleep patterns during inpatient treatment of methamphetamine withdrawal: A comparison of mirtazapine and modafinil with treatment as usual. [2008.03.06]
Cognitive-behavioural therapy v. mirtazapine for chronic fatigue and neurasthenia: randomised placebo-controlled trial. [2008.03]
A meta-analysis of clinical trials comparing mirtazapine with selective serotonin reuptake inhibitors for the treatment of major depressive disorder. [2008.02.28]
Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression. [2008.02]
Premedication with mirtazapine reduces preoperative anxiety and postoperative nausea and vomiting. [2008.01]
Outcomes after isolated mirtazapine (Remeron) supratherapeutic ingestions. [2008.01]
Effectiveness of mirtazapine in the treatment of depression with associated somatic symptoms. [2008.01]
An open-label long-term naturalistic study of mirtazapine treatment for depression in cancer patients. [2008]
Tai-Kang-Ning, a Chinese herbal medicine formula, alleviates acute heroin withdrawal. [2008]
Add-on mirtazapine enhances effects on cognition in schizophrenic patients under stabilized treatment with clozapine. [2007.12]
Receptor occupancy of mirtazapine determined by PET in healthy volunteers. [2007.11]
Enhancing effect of mirtazapine on cognitive functions associated with prefrontal cortex in patients with recurrent depression. [2007.10]
Mirtazapine in progressive multifocal leukoencephalopathy associated with polycythemia vera. [2007.09.01]
Mirtazapine for the treatment of hot flushes in breast cancer survivors: a prospective pilot trial. [2007.09]
Mirtazapine for anorexia nervosa with depression. [2007.09]
Association study of the serotonin transporter promoter polymorphism and mirtazapine antidepressant response in major depressive disorder. [2007.08.15]
Mirtazapine does not affect pentylenetetrazole- and maximal electroconvulsive shock-induced seizures in mice. [2007.08]
Receptor occupancy of mirtazapine determined by PET in healthy volunteers. [2007.07.25]
Cancer chemotherapy and cachexia: mirtazapine and olanzapine are 5-HT3 antagonists with good antinausea effects. [2007.07]
Effects of combination treatment with mood stabilizers and mirtazapine on plasma concentrations of neuroactive steroids in depressed patients. [2007.07]
Pharmacokinetics of mirtazapine: enantioselective effects of the CYP2D6 ultra rapid metabolizer genotype and correlation with adverse effects. [2007.05]
Venlafaxine-mirtazapine combination in the treatment of persistent depressive illness. [2007.03]
Transfer of the antidepressant mirtazapine into breast milk. [2007.03]
[Driving Ability of Depressive Patients under Mirtazapine and Reboxetine.] [2007.01]
Mirtazapine monotherapy versus combination therapy with mirtazapine and aripiprazole in depressed patients without psychotic features: A 4-week open-label parallel-group study. [2007]
|
